| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9196 |
| Human Intestinal Absorption | HIA+ | 0.9636 |
| Caco-2 Permeability | Caco2+ | 0.6861 |
| P-glycoprotein Substrate | Non-substrate | 0.5683 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8800 |
| Non-inhibitor | 0.9661 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8722 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9097 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7725 |
| CYP450 2D6 Substrate | Non-substrate | 0.8998 |
| CYP450 3A4 Substrate | Non-substrate | 0.6812 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5534 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7757 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9118 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6651 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9431 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9166 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9533 |
| Non-inhibitor | 0.9362 |
| AMES Toxicity | Non AMES toxic | 0.9387 |
| Carcinogens | Non-carcinogens | 0.8129 |
| Fish Toxicity | High FHMT | 0.9465 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9980 |
| Honey Bee Toxicity | High HBT | 0.5271 |
| Biodegradation | Ready biodegradable | 0.9402 |
| Acute Oral Toxicity | III | 0.9119 |
| Carcinogenicity (Three-class) | Non-required | 0.5829 |